These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

240 related articles for article (PubMed ID: 31752040)

  • 21. Platelet concentrates transfusion in cardiac surgery and platelet function assessment by multiple electrode aggregometry.
    Rahe-Meyer N; Winterhalter M; Boden A; Froemke C; Piepenbrock S; Calatzis A; Solomon C
    Acta Anaesthesiol Scand; 2009 Feb; 53(2):168-75. PubMed ID: 19175576
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Transfusion requirements in elective cardiopulmonary bypass surgery patients: predictive value of Multiplate and Thromboelastography (TEG) Platelet Mapping Assay.
    Sivapalan P; Bäck AC; Ostrowski SR; Ravn HB; Johansson PI
    Scand J Clin Lab Invest; 2017 Sep; 77(5):345-351. PubMed ID: 28537454
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The central role of the P(2T) receptor in amplification of human platelet activation, aggregation, secretion and procoagulant activity.
    Storey RF; Sanderson HM; White AE; May JA; Cameron KE; Heptinstall S
    Br J Haematol; 2000 Sep; 110(4):925-34. PubMed ID: 11054084
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Clopidogrel (Plavix) and cardiac surgical patients: implications for platelet function monitoring and postoperative bleeding.
    Tanaka KA; Szlam F; Kelly AB; Vega JD; Levy JH
    Platelets; 2004 Aug; 15(5):325-32. PubMed ID: 15370104
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Multiple Electrode Aggregometry After Cardiopulmonary Bypass to Assess Platelet (Dys)-Function and Transfusion Threshold: A Concordance Study.
    Auci E; Vetrugno L; Riccardi I; Brussa A; Orso D; Baroselli A; Gigante A; Cecotti R; Bassi F; Livi U; Bove T
    J Cardiothorac Vasc Anesth; 2020 Dec; 34(12):3306-3313. PubMed ID: 32684430
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Platelet dysfunction after normothermic cardiopulmonary bypass in children: effect of high-dose aprotinin.
    Flaujac C; Pouard P; Boutouyrie P; Emmerich J; Bachelot-Loza C; Lasne D
    Thromb Haemost; 2007 Aug; 98(2):385-91. PubMed ID: 17721621
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Use of autologous umbilical cord blood transfusion in neonates undergoing surgical correction of congenital cardiac defects: A pilot study.
    Sarin K; Chauhan S; Bisoi AK; Hazarika A; Malhotra N; Manek P
    Ann Card Anaesth; 2018; 21(3):270-274. PubMed ID: 30052213
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Platelet function analysed by ROTEM platelet in cardiac surgery after cardiopulmonary bypass and platelet transfusion.
    Kjellberg G; Holm M; Lindvall G; Gryfelt G; van der Linden J; Wikman A
    Transfus Med; 2020 Oct; 30(5):369-376. PubMed ID: 32196802
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The quantitative and qualitative responses of platelets in pediatric patients undergoing cardiopulmonary bypass surgery.
    Ignjatovic V; Than J; Summerhayes R; Newall F; Horton S; Cochrane A; Monagle P
    Pediatr Cardiol; 2012 Jan; 33(1):55-9. PubMed ID: 21809131
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Performance of functional fibrinogen thromboelastography in children undergoing congenital heart surgery.
    Gautam NK; Cai C; Pawelek O; Rafique MB; Cattano D; Pivalizza EG
    Paediatr Anaesth; 2017 Feb; 27(2):181-189. PubMed ID: 27901294
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Early platelet recovery following cardiac surgery with cardiopulmonary bypass.
    Van Poucke S; Stevens K; Wetzels R; Kicken C; Verhezen P; Theunissen M; Kuiper G; van Oerle R; Henskens Y; Lancé M
    Platelets; 2016 Dec; 27(8):751-757. PubMed ID: 27164510
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Preoperative hemostasis and its association with bleeding and blood component transfusion requirements in cardiopulmonary bypass surgery.
    Emeklibas N; Kammerer I; Bach J; Sack FU; Hellstern P
    Transfusion; 2013 Jun; 53(6):1226-34. PubMed ID: 22934739
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Point of care testing in children undergoing cardiopulmonary bypass.
    Tirosh-Wagner T; Strauss T; Rubinshtein M; Tamarin I; Mishaly D; Paret G; Kenet G
    Pediatr Blood Cancer; 2011 May; 56(5):794-8. PubMed ID: 21370413
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A rapid platelet function assay used to regulate platelet transfusion prophylaxis following cardiopulmonary bypass surgery.
    Shaffer KE; Pearman DT; Galen RS; Carville DG
    J Extra Corpor Technol; 2004 Jun; 36(2):145-8. PubMed ID: 15334754
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Platelet-rich plasma sequestration, with therapeutic platelet yields, reduces allogeneic transfusion in complex cardiac surgery.
    Stover EP; Siegel LC; Hood PA; O'Riordan GE; McKenna TR
    Anesth Analg; 2000 Mar; 90(3):509-16. PubMed ID: 10702428
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The Effects of Steroids on Coagulation Dysfunction Induced by Cardiopulmonary Bypass: A Steroids in Cardiac Surgery (SIRS) Trial Substudy.
    Paparella D; Parolari A; Rotunno C; Vincent J; Myasoedova V; Guida P; De Palo M; Margari V; Devereaux PJ; Lamy A; Alamanni F; Yusuf S; Whitlock R
    Semin Thorac Cardiovasc Surg; 2017 Spring; 29(1):35-44. PubMed ID: 28683994
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A single dose of aprotinin prevents platelet hyporeactivity after coronary artery bypass graft surgery.
    Szczeklik W; Morawski W; Sanak M; Jakieła B; Bolkowski M; Cisowski M; Szczeklik M; Bochenek A; Musiał J
    Pol Arch Med Wewn; 2010 Sep; 120(9):321-7. PubMed ID: 20864904
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Platelet function during cardiopulmonary bypass using multiple electrode aggregometry: comparison of centrifugal and roller pumps.
    Kehara H; Takano T; Ohashi N; Terasaki T; Amano J
    Artif Organs; 2014 Nov; 38(11):924-30. PubMed ID: 24720284
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The GP IIb/IIIa inhibitor abciximab (ReoPro) decreases activation and interaction of platelets and leukocytes during in vitro cardiopulmonary bypass simulation.
    Straub A; Wendel HP; Azevedo R; Ziemer G
    Eur J Cardiothorac Surg; 2005 Apr; 27(4):617-21. PubMed ID: 15784360
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Enhanced platelet aggregation and activation under conditions of hypothermia.
    Xavier RG; White AE; Fox SC; Wilcox RG; Heptinstall S
    Thromb Haemost; 2007 Dec; 98(6):1266-75. PubMed ID: 18064324
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.